From Mendel to Gene Therapy.

Jeffrey, Samantha L; Brigham, Don A; Chawla, Sant P; Federman, Noah; Hall, Frederick L; Gordon, Erlinda M

Jeffrey, Samantha L; Brigham, Don A; Chawla, Sant P; Federman, Noah; Hall, Frederick L; Gordon, Erlinda M.

Afiliação

Jeffrey SL; University of California, Los Angeles, CA, U.S.A.
Brigham DA; Aveni Foundation, Santa Monica, CA, U.S.A.
Chawla SP; Cancer Center of Southern California/Sarcoma Oncology Research Center, Santa Monica, CA, U.S.A.
Federman N; University of California, Los Angeles, CA, U.S.A.
Hall FL; Aveni Foundation, Santa Monica, CA, U.S.A.
Gordon EM; Aveni Foundation, Santa Monica, CA, U.S.A.; egordon@sarcomaoncology.com.

Anticancer Res ; 43(10): 4257-4261, 2023 10.

Article em En | MEDLINE | ID: mdl-37772566

Palavras-chave

CAR-T cell therapy; DeltaRex-G; Gregor Mendel; Holy Grail of Gene Therapy; Watson & Crick; adenoassociated vector; gene therapy; human genome project; retroviral vector; targeted gene delivery

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article